Given that gut flora and related metabolites substantially impact inflammation, insulin signaling, and glucose and lipid metabolism [15,16,20], GDM might be connected to disruptions in the gut microbiota and related metabolites, especially SCFAs. This evidence concerns the gene INS and gestational diabetes.